Literature DB >> 8117195

Do long-standing nodular goitres result in malignancies?

V Mathai1, J Idikula, A S Fenn, A Nair.   

Abstract

The records of 506 patients with histologically proven nodular goitre treated by thyroidectomy between January 1966 and July 1988 were reviewed. There were 21 patients with thyroid carcinoma in nodular goitre giving a proportion of 4.1%. There was an almost equal ratio of papillary to follicular carcinomas in the patients with malignancy occurring in a multinodular goitre (11 papillary to 9 follicular). One had an anaplastic lesion. These patients had swelling for a longer period, 9.11 years, as compared with an average of 5.48 years for those with only nodular goitre (P = < 0.01) using the Student's t-test. The male to female ratio in those with multinodular goitre alone was 1:10.8 while in those with carcinoma in multinodular goitre was 1:3.2. Comparing these two groups, the odds ratio of malignancy among males was 2.82 (95% confidence limits of the odds ratio being 1.4-5.5). This indicates that males with multinodular goitre had a significantly higher chance of developing a malignancy, Chi-squared value 5.74 (P < 0.05).

Entities:  

Mesh:

Year:  1994        PMID: 8117195     DOI: 10.1111/j.1445-2197.1994.tb02173.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  6 in total

1.  Malignancy rate in nondominant nodules in patients with multinodular goiter: Experience with 1,606 cases evaluated by ultrasound-guided fine needle aspiration cytology.

Authors:  Nadir Paksoy; Kadri Yazal; Selin Corak
Journal:  Cytojournal       Date:  2011-10-31       Impact factor: 2.091

2.  Prevalence of differentiated thyroid cancer in 810 cases of surgically treated goiter in Yemen.

Authors:  Mansour Al-Jaradi; Abdulkhalik Sallam; Hikmat Jabr; Angela Borda; Myriam Decaussin-Petrucci; Nicole Berger
Journal:  Ann Saudi Med       Date:  2005 Sep-Oct       Impact factor: 1.526

3.  Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors.

Authors:  Gabriella Pellegriti; Francesco Frasca; Concetto Regalbuto; Sebastiano Squatrito; Riccardo Vigneri
Journal:  J Cancer Epidemiol       Date:  2013-05-07

4.  Microarray analysis of thyroid stimulating hormone, insulin-like growth factor-1, and insulin-induced gene expression in FRTL-5 thyroid cells.

Authors:  You Jin Lee; Do Joon Park; Chan Soo Shin; Kyong Soo Park; Seong Yeon Kim; Hong Kyu Lee; Young Joo Park; Bo Youn Cho
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

5.  Incidence and histological patterns of thyroid cancer in Sri Lanka 2001-2010: an analysis of national cancer registry data.

Authors:  Umesh Jayarajah; Ashan Fernando; Saumyakala Prabashani; Eshani A Fernando; Sanjeewa A Seneviratne
Journal:  BMC Cancer       Date:  2018-02-07       Impact factor: 4.430

6.  Thyroid Cancer and Iodine Deficiency Status: A 10-Year Review at a Single Cancer Center in Tanzania.

Authors:  Lulu L Sakafu; Teddy F Mselle; Julius D Mwaiselage; Khamza K Maunda; Bouyoucef S Eddin; Mark E Zafereo
Journal:  OTO Open       Date:  2018-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.